Overview
Peter Rimensberger practices in Geneve, Switzerland. Mr. Rimensberger is rated as an Experienced expert by MediFind in the treatment of CLN1 Disease. His top areas of expertise are Infant Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome (ARDS), Premature Infant, and Multisystem Inflammatory Syndrome in Children (MIS-C).
His clinical research consists of co-authoring 90 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of CLN1 Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Infant Respiratory Distress SyndromeMr. Rimensberger isDistinguished. Learn about Infant Respiratory Distress Syndrome.
- Advanced
- Acute Respiratory Distress Syndrome (ARDS)Mr. Rimensberger isAdvanced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- Experienced
- Batten DiseaseMr. Rimensberger isExperienced. Learn about Batten Disease.
- Cerebral HypoxiaMr. Rimensberger isExperienced. Learn about Cerebral Hypoxia.
- CLN1 DiseaseMr. Rimensberger isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseMr. Rimensberger isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseMr. Rimensberger isExperienced. Learn about CLN3 Disease.
- CLN4 DiseaseMr. Rimensberger isExperienced. Learn about CLN4 Disease.